InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,704.80
(
0.01%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
78.70
(
-0.46%
)
Bitcoin
62,860.51
(
4.30%
)
Post# of 253343
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 70096

Saturday, 02/20/2010 8:59:44 AM

Saturday, February 20, 2010 8:59:44 AM

Post# of 253343
New FDA warning and safety controls for long-acting beta agonists (LABA):

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm200931.htm

These recommendations might reduce the use of LABA drugs as monotherapy (Servent, Foradil) and in combination with ICS (Advair, Symbicort) but increase ICS monotherapy agents such as Pulmicort and Singulair (leukotriene receptor antagonist).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up